Cargando…
Efficacy and safety of autologous peripheral blood stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia: A study protocol for a multicenter exploratory prospective study (Auto-Ph17 study)
INTRODUCTION: The prognosis of Philadelphia chromosome positive acute lymphoblastic leukemia (Ph + ALL) has been dramatically improved since the introduction of tyrosine kinase inhibitors (TKIs). Although allogeneic hematopoietic cell transplantation (allo-HCT) is a major treatment option, the role...
Autores principales: | Nishiwaki, Satoshi, Sugiura, Isamu, Miyata, Yasuhiko, Saito, Shigeki, Sawa, Masashi, Nishida, Tetsuya, Miyamura, Koichi, Kuwatsuka, Yachiyo, Kohno, Akio, Yuge, Masaaki, Kasai, Masanobu, Iida, Hiroatsu, Kurahashi, Shingo, Osaki, Masahide, Goto, Tatsunori, Terakura, Seitaro, Murata, Makoto, Nishikawa, Hiroyoshi, Kiyoi, Hitoshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6393033/ https://www.ncbi.nlm.nih.gov/pubmed/29384978 http://dx.doi.org/10.1097/MD.0000000000009568 |
Ejemplares similares
-
Autologous peripheral blood stem cell transplantation for Philadelphia chromosome‐positive acute lymphoblastic leukemia is safe but poses challenges for long‐term maintenance of molecular remission: Results of the Auto‐Ph17 study
por: Nishiwaki, Satoshi, et al.
Publicado: (2023) -
Machine learning-aided risk stratification in Philadelphia chromosome-positive acute lymphoblastic leukemia
por: Nishiwaki, Satoshi, et al.
Publicado: (2021) -
Multi-Lineage BCR-ABL Expression in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Is Associated With Improved Prognosis but No Specific Molecular Features
por: Nishiwaki, Satoshi, et al.
Publicado: (2020) -
High-risk Combinations of Additional Chromosomal Abnormalities in Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia: JALSG Ph+ALL TKI-SCT Study
por: Nishiwaki, Satoshi, et al.
Publicado: (2023) -
Phase I study of cord blood transplantation with intrabone marrow injection of mesenchymal stem cells: A clinical study protocol
por: Goto, Tatsunori, et al.
Publicado: (2018)